A Laser-Azogui, T Diamant-Levi, S Israeli, Y Roytman and I Tsarfaty Met tyrosine kinase has been implicated in tumorigenesis and metastasis; its overexpression and deregulation is often observed in cancer. Although Met's functions in cell motility has been studied extensively, its involvement in bleb-based, amoeboid motility is yet to be determined. The aim of this work is to study the role of Met in amoeboid cell motility and invasion. We show that aggressive breast cancer cells expressing high levels of endogenous Met, as well as HEK293T cells over expressing fluorescent Met, exhibit constitutive, ligand-independent Met activation, leading to Met-dependent membrane blebbing and amoeboid cell motility; HEK293T cells over expressing fluorescent Met were able to invade in three-dimensional matrix. Hyper-activated Met mutant significantly enhances blebbing and cell motility. Met inhibition by either a Met-specific inhibitor or by exogenous expression of a dominant-negative Met remarkably repressed membrane blebbing and invasion. Inhibition of Rho signaling pathway by a ROCK inhibitor also represses Met-induced blebbing, suggesting that Met regulates the blebbing machinery through Rho-ROCK pathway, which controls the actin-myosin contractile force. Either de-polymerization or hyper-polymerization of the actin cytoskeleton abrogates Met-induced blebbing, signifying that actin polymerization has a role in halting and retracting Met-induced mature blebs. Indeed, when blebs retract, membrane wrinkles containing high levels of Met and actin are generated, indicating localized formation of Met-signaling microdomains. We suggest that this bleb-based activity is induced by amplification of Met signaling in unique membrane domains generated by bleb retraction. Our results indicate that Met-induced blebbing has an important role in cell detachment, amoeboid motility and invasion ability, which are utilized by cancer cells for migration and metastasis.
INTRODUCTION
Met receptor tyrosine kinase promotes tumor growth and metastasis by enhancing motility, survival and proliferation of cancer cells and stimulating angiogenesis. 1, 2 The ligand that activates Met is hepatocyte growth factor/scatter factor (HGF/SF). 3 Met-dependent invasive growth is a characteristic of aggressive tumors, from which cells disaggregate, invade distal tissues and establish metastases. 4 Several Met targeting agents have been introduced into the clinic, and are currently in all phases of clinical trials. 5 Some of these agents have shown impressive evidence of clinical activity in a wide range of tumor types. 6 Metastatic cells dissociate from the primary tumor in order to migrate and invade distal organs. This can occur in two modes: the first is the mesenchymal motility mode, which is motivated by dynamic remodeling of the actin cytoskeleton at the leading edge and utilizes ECM proteolytic degradation to move forward ('path-generating'). The second is amoeboid motility mode, which is characterized by rounded cell shape; it lacks focal contacts and is much less adhesive, thus allows cells to detach from a tumor and metastasize. These cells use proteaseindependent physical mechanisms to bypass matrix barriers ('path finding'), involving extreme shape adaptations. Such shape-driven migration allows cells to circumnavigate, instead of degrade, their ECM barriers. 7, 8 Characteristic of amoeboid migration is the formation of membrane blebs, bubble-like protrusions characterized by sudden formation. Blebbing is observed during migration of several cell types. 9, 10 Induction of membrane blebbing in noninvasive cells enhances their ability to invade three-dimensional matrices. 11 Actin-myosin contractility for bleb retraction is provided by signaling through Rho-ROCK; 8, [11] [12] [13] [14] inhibition of ROCK suppresses membrane blebbing, 15 and epithelial cells expressing a constitutively active RhoA can detach from the epithelial sheets and acquire a rounded bleb-associated mode of motility. 16 Although Met is a potent motility and invasion factor, 17, 18 its role in membrane blebbing and amoeboid cell motility is poorly documented. A link between Met and membrane blebbing has been demonstrated in invasive MSV-MDCK-INV cells [19] [20] [21] as well as in SCLC cells, 22 both expressing constitutively activated Met. The aim of this work was to study the role of Met-induced blebbing in cell motility and metastasis. We demonstrate that Met-induced blebbing is a dynamic process leading to alteration in cell morphology, formation of Met-microdomains, dissociation and detachment of tumor cells and subsequent invasion through 3D matrix.
RESULTS

Breast cancer cells expressing high levels of activated Met form membrane blebbing
To examine the expression levels of Met in different breast cancer (BC) cell lines, we performed WB analysis using antibodies against total and phosphorylated Met (Figure 1a ). MDA231 (lanes 4-6) and BT549 (lanes 13-15) cells express high levels of Met and high levels of phosphorylated Met, independent of HGF/SF. T47D (lanes 1-3) and MCF7 (lanes 10-12) cells express low levels of Met. Met phosphorylation levels are low in T47D and MCF7 cells, and are not affected by HGF/SF. The normal breast cells HB2 express moderate levels of Met, and its phosphorylation level, which is very low in the absence of HGF/SF, significantly increases shortly after HGF/SF addition (lanes 7-9). Screening of these cells for motile behavior revealed remarkable morphological differences between cells expressing low/moderate Met levels and cells expressing high Met levels. MCF7 and T47D cells were flat, adhesive and clustered, even when plated at low concentrations. They were completely immobile and morphologically static, and no blebbing was observed. HGF/SF treatment did not induce any membrane blebbing in these cells (Figure 1b) . In contrast, HB2, MDA231 and BT549 exhibited various shapes, and several of them were blebbing (Figure 1b, Images of at least 10 fields were taken for each cell line and each treatment (untreated, HGF/SF, PHA665752 and DN-YFP-Met). Total and blebbing cells were counted in each field, and percentages were calculated. t-Tests were applied to demonstrate statistical significance of the differences between treatments (*Po0.005, **Po0.05).
presence of HGF/SF (Figure 1c , P ¼ 0. 23 and screened for membrane blebbing. Only 7% of MDA231 cells expressing DN-YFP-Met showed membrane blebbing (Figure 1b  and c) . In addition, MDA231 and BT549 cells treatment with 5 mM PHA665752, a Met-specific inhibitor, for 4 h significantly reduced the percentage of blebbing cells ( Figure 1b and c) ; only 9.2% of MDA231 cells and 20.7% of BT549 cells were blebbing following PHA665752 treatment, compared with 44.7% and 34.6%, respectively, of untreated cells (n ¼ 10, Po0.005 for both cell lines).
Constitutive FP-Met activation induces cell rounding and membrane blebbing To further study the association between Met overexpression and membrane blebbing, we generated a model system of 293T cells exogenously overexpressing fluorescent-tagged Met (293T-FP-Met). 293T cells express very low levels of endogenous Met. We first validated that following transfection, FP-Met is overexpressed and is localized to the plasma membrane as previously demonstrated for GFP-Met, 24 indicating proper expression, maturation and trafficking of the fusion protein to the plasma membrane (Figure 2Ba ).
We performed IP and WB for Met ( (C) DN-YFP-Met reduces FP-Met-induced blebbing frequency. Blebbing rate quantization: 293T cells were transfected with the indicated constructs. Twenty-four hours after transfection cells were treated with HGF/SF where indicated and subjected to time-lapse confocal laser scanning microscopy (CLSM) using Zeiss 510 confocal microscope. Single cells were monitored for several minutes. Newly formed blebs per minute were counted for each cell (n ¼ 11, *Po0.01 **Po0.05).
Met-induced amoeboid cell motility and invasion A Laser-Azogui et al present in retracting blebs. Figure 5b shows that Met and actin intensity (green and red curves) is increased in correlation with bleb retraction (blue curve represents bleb size). The increase in Met and actin levels is correlated, with Met preceding that of actin by B40 s. Quantization of Met and actin intensity levels demonstrate similar increase in the two proteins' concentration ( Figure 5c ). These results show that both Met and Actin levels are elevated during bleb retraction and they co-accumulate in Met-microdomains of retracted blebs. The signal transduction pathway between Met and actin is likely to involve RhoA GTPase, since Rho-ROCK involvement in the execution of all types membrane blebbing was demonstrated. 8, [11] [12] [13] [14] [15] To examine Met-induced blebbing (n ¼ 30, Po0.001), indicating a role for the actin cytoskeleton in bleb dynamics.
Met-induced membrane blebbing correlates with cell dissociation To test whether Met-induced blebbing has a role in cell motility, we first monitored the behavior of blebbing BC cells. Blebbing MDA231 and BT549 cells underwent dynamic shape changes together with dissociation from the surface and from neighboring cells, and cell translocation. Monitoring the dissociation and translocation process of BT549 cells (Figure 6a ), we found that blebbing BC cells are highly motile and characterized by rapid shape changes. Once the dissociation process initiates, it is very fast (only few minutes), and results in the translocation of the cell body. In Figure 6a , during 4 min the left cell moves B100 mm and the right cell B50 mm.
To verify that the cell rounding and dissociation process is induced by Met, we monitored the initiation of YFP-Met expression, the elevation in its expression levels over a few hours and the subsequent cell rounding. In parental 293T cells, acquisition of a rounded phenotype was evidenced only during mitosis and included rounding, division and re-adhesion of the daughter cells (Figure 6b , arrows indicate the cell undergoing mitosis). The whole process takes 98.8±15.44 min (n ¼ 10) and is always transient; the daughter cells always switched back to flat and adherent morphology.
In contrast, rounding of 293T-FP-Met was tightly correlated with the elevation in YFP-Met expression ( Figure 6c) ; the cells remained rounded for as long as we monitored them, which is at least 257.6 ± 148.5 min (n ¼ 10), which is at least 2.5-fold longer than the parental rounding during mitosis (Po0.005, Figure 6d ). The process appeared to be irreversible, as none of the monitored cells switched back to flat adherent morphology. We conclude that the cell rounding is Met-specific and requires the Met TK activity, as other constructs expressed in this system induced neither cell rounding nor any other morphological alterations (see YFP-Mem and DN-YFP-Met in Figure 2B ).
To further confirm that the rounding and dissociation behavior leads to complete detachment of cells from their surroundings, we counted detached cells in Parental 293T (control) group, 293T-FPMet group and cells mutated YFP-Met (M1268T/L1213V activating mutations) 26, 27 group. Cells expressing YFP-Met bearing M1268T/ L1213V activating mutations exhibited significantly more detachment events (at least by two-fold) than cells expressing WT YFP-Met (Figure 6e , n ¼ 6 plates, Po0.05), which exhibited significantly more detachment events (at least by eight-fold) than control cells (Figure 6e , n ¼ 6 plates, Po0.05). Trypan blue staining showed that only 10% of the detached cells in all experimental groups are dead (data not shown), indicating that the detachment is not coupled to cell death.
293T-FP-Met cells migrate and invade 3D substrates
To demonstrate that the phenotype and behavior of 293T-FP-Met cells indicate an ability to metastasize, we performed invasion assay on Matrigel-coated transwell inserts. 293T-FP-Met cells invasion was significantly higher (B8-fold) than 293T-DN-YFPMet or 293T-YFP-N1 cells (Figure 7 ).
DISCUSSION
Deregulation of Met is critical for the acquisition of invasive phenotype and metastasis. 17 Met might be constitutively activated in a ligand-independent manner due to mutations, amplification or overexpression (reviewed in 28, 29 ) , which is the most frequent alteration of Met-induced motility. 17, 18, 20 We show that aggressive BC cells expressing high levels of constitutively activated endogenous Met, as well as 293T cells over expressing fluorescent Met, exhibit membrane blebbing leading to amoeboid cell motility and invasion in 3D matrix. Profound morphological differences were observed between blebbing and non-blebbing cells; whereas low-Met expressing, non-blebbing BC cells (MCF7 and T47D) were adherent, morphologically static and clustered, MDA231 and BT549 cells dynamically changed their shape and were much less adherent. This resulted in cell-cell and cell-substrate dissociation. We showed that once the dissociation process initiates, it is rapid and results in the translocation of the cell body. Similarly, 293T-FP-Met cells transitioned to a rounded, much less adherent morphology and tended to dissociate and detach in temporal correlation with elevation in FP-Met expression. These alterations were permanent and irreversible, since the overexpression of YFP-Met would not allow the cells to retain their adherent morphology. FP-Met expressing cells dissociate and detach significantly more than parental cells, and M1268T/L1213V mutated Met expressing cells dissociate and detach significantly more than the FP-Met. Similar to membrane blebbing, the rounding and de-adhesion processes occurred only in cells expressing intact FP-Met; cells expressing DN-YFP-Met or a membrane marker exhibited neither cell rounding nor dissociation. Complete dissociation results in suspended, round cells that displayed prominent membrane blebbing; this is not surprising, as acquisition of a rounded cell shape is a part of the dissociation process towards migration of cancer cells utilizing amoeboid motility. 8, 30 Suspended detached cells viability was confirmed, in strong agreement with increased anchorage-independent survival associated with metastatic cells and Met expressing cells especially; metastatic cells' survival is facilitated by Met-induced protection from apoptosis and the ability to transiently survive in an anchorage-independent manner, 31 to allow metastasis and establishment of new populations by these Met expressing cancer cells.
These results clearly show that membrane blebbing is induced by active Met receptor, and demonstrate, for the first time as far as we know, that Met may motivate the process of membrane blebbing and promote amoeboid motility and invasion. These findings have significant implications for Met-induced metastasis and anti-Met targeted cancer therapy. We have shown that the extension of 293T-FP-Met blebs is motivated by cytoplasmic fluid pressure, probably following localized detachment of the plasma membrane from its supporting actin cortex, as suggested by several studies to be the general cell machinery for bleb formation. 12, 32 It is possible that bleb formation is initiated by Met-induced local actin de-polymerization, followed by detachment of a patch of the plasma membrane from the underlying actin cortex. The patch of unbound membrane is inflated by intracellular fluid flow to form a protrusion filled with cytosol devoid of cytoskeletal structures. Our analyses also demonstrated that the expanding bleb does not contain significant amounts of cortical actin, further demonstrating that bleb growth is not motivated by cytoskeleton polymerization at the leading edge. It was previously established that actin is subsequently polymerized at the bleb cortex to halt bleb expansion, and actomyosin contractility is generated to retract the bleb. 32, 33 We addressed the possible interaction of Met and actin during the lifecycle of a bleb, and show that Met and actin co-accumulate underneath the bleb membrane during bleb retraction, with Met accumulation precedes that of actin by B40 s. Disruption of actin dynamics with either hyper-polymerization by jaspamide or de-polymerization by Latrunculin A abrogated membrane blebbing, further confirming that actin is required for the blebbing to occur.
The signal transduction pathway between Met and the contractile machinery is likely to involve RhoA GTPase and its kinase ROCK; inhibition of ROCK significantly reduced the number of blebbing cells in this study. This is not surprising as Rho-ROCK involvement in the execution of membrane blebbing was widely reported for all types of blebs. 8, [11] [12] [13] [14] [15] Blebs retraction results in membrane wrinkles that may considerably elevate membrane surface area in these domains, in correlation to the accumulation of Met and actin. Such co-accumulation can be attributed to the large surface area of these domains and may indicate hyper activation of Met and subsequent signal amplification; these results lead us to suggest that Met-induced membrane blebbing also promotes the formation of specific membrane microdomains as a mode to amplify Met signaling. Plasma membrane microdomains or signaling platforms 34 facilitate the coordinated assembly of many different membrane-bound components to carry out signaling. [35] [36] [37] It has been recently shown that Met can signal through specific domains named dorsal ruffles, actin-rich protrusions generated in response to growth factors, which function as both localized signaling and internalization platform. 38, 39 Signaling microdomains require actin cytoskeleton for their assembly, maintenance and mobilization and localization of membrane receptors. 40, 41 The co-accumulation of Met and actin in bleb retraction microdomains strongly suggests that these domains serve as signaling platforms in tumor cells. We hypothesize that the formation of Met-microdomains allow further activation of Met and amplification of downstream signaling; We suggest a positive-feedback model for Met signaling, in which Met-induced blebbing has a dual role, first in the promotion of cell dissociation towards motility, and second in localized enhancement of Met signaling, by generating transient clusters of Met and its substrates.
Taken together, our results indicate that Met-induced blebbing leads to motility and invasion of cancer cells, and may also have a role in amplification of Met signaling. A better understanding of the cellular and molecular mechanisms underlying Met-induced membrane blebbing may shed a light on the mechanisms controlling metastatic development, and promote the development of targeted therapy to specifically block Met-induced blebbing and thus reduce metastasis.
MATERIALS AND METHODS
Cells, media and reagents HEK293T (will be referred to as 293T), MCF7 and MDA-MB-231 cell lines were purchased from ATCC (Manassas, VA, USA). T47D and HB2 cells were a gift from Professor Iafa Keydar, Tel Aviv University and Dr Joyce Taylor-Papadimitriou, King's College, respectively. All cells, except BT549, which were cultured in RPMI 1640, were cultured in high-glucose DMEM supplemented with 10% FCS (Invitrogen, Carlsbad, CA, USA) and PSN antibiotics cocktail (Biological Industries, Bet-Haemek, Israel). HB2 cells media were also supplemented with 5 mg/ml hydrocortisone and 10 mg/ml insulin (Sigma, St Louis, MO, USA). HGF/SF was prepared in our laboratory as previously described. 42 Reagents purchased from the following companies: PHA665752 (Tocris Bioscience, Bristol, UK), Jasplakinolide and Latrunculin A (Invitrogen), Y-27632 (Cayman Chemical Company, Ann Arbor, MI, USA).
DNA transfection
Transfections of 293T cells were performed using the calcium phosphate method. 43 Transfections of breast cells were performed using the Lipofectin reagent kit (Invitrogen) according to manufacturer's protocol. Plasmids GFP-Met was generated by cloning the met gene into EGFP-N1. 24 YFP-Met, CFP-Met and mCherry-Met were constructed similarly using pEYFP-N1, pECFP-N1 and pmCherry-1vectors (Clontech, Mountain View, CA, USA). To generate DN-YFP-Met, The PCR product of the DN-Met sequence from the construct pMBTDN 23 was cloned into pEYFP-N1. YFP-Actin and YFP-Mem were purchased from Clontech.
Point mutation mutagenesis
Activating mutations in the TK domain of YFP-Met were produced by site directed mutagenesis using QuickChange kit (Agilent Technologies, Santa Clara, CA, USA), according to manufacturer's protocol. Using pEYFP-Met as a template, a double mutation L1213V/M1268T was established by two PCRs: first to generate the M1268T mutation with the following primers (the mutated nucleotide is emphasized):
3'-CGGTTCGATGGTCATTTCACCTGCCGAAATCTCTCAGACG-5' and 5'-GCC AAGCTACCAGTAAAGTGGACGGCTTTAGAGAGTCTGC-3' Second, using M1268T pEYFP-Met mutant as a template was performed to generate the, L1213V mutation with the following primers: 3 0 -CGGTTTCCGTACTTTATACAACGGTCGTTTTTCAAACAGG-5 0 and 5 0 -GCC AAAGGCATGAAATATGTTGCCAGCAAAAAGTTTGTCC-3 0 Following PCR, restriction enzyme DpnI was used for digestion of methylated parental cDNA. The mutations were verified by sequencing.
Immunoprecipitation and western blot IP and WB were performed as described 24 using SP260 anti mouse Met antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) for IP, and B-2 anti-mouse Met, C-12 anti-human Met (Santa Cruz), anti-pMet(TK) and anti-pMet(docking) (Invitrogen) for WB.
FACS analysis for apoptosis
Cells were transfected with the indicated constructs. Six hours after transfection, medium was changed and 100 ng/ml HGF/SF or 1 mM staurosporine (Sigma) as a positive control for apoptosis were added where indicated. Cell samples were processed for FACS and suspended in PBS containing propidium iodide (Sigma) and RNAse (Roche, Indianapolis, IN, USA). Samples were analyzed using FACSAria (BD Biosciences, San Jose, CA, USA).
TUNEL assay for apoptosis
Cells were transfected with mCherry-Met construct where indicated. As a positive control for apoptosis, cells were treated with 1 mM staurosporine for 18 h at 37 1C. 25 Cells were fixed, stained with DAPI (Sigma) and subjected to TUNEL assay (Promega, Madison, WI, USA) according to manufacturer's protocol.
Cell detachment assay
293T cells were transfected with the indicated constructs. Twenty-four hours later, the supernatant containing detached cells was collected and centrifuged. The pellet was resuspended and cells were counted.
Trypan blue staining
Media containing detached cells were centrifuged for 5 min. Pellet was resuspended in 1 ml PBS. One millimeter of 0.4% trypan blue/PBS solution (Sigma) was added and the mixture was incubated for 3 min. Unstained (viable) and stained (nonviable) cells were counted using hemacytometer and percentage of nonviable cells was calculated.
Invasion assay 293T cells were transfected with mCherry-Met plasmid or an empty YFP-N1 plasmid for control. A total of 3 Â 10 4 cells were seeded in DMEM containing 1% BSA on Matrigel (1:4.5, Collaborative Biomedical Products, Bedford, MA, USA 01730)-coated transwell inserts, 6.5 mm diameter and 8 mm-pore polycarbonate filter membrane inserts (Corning Incorporated, Corning, NY, USA). The basolateral chambers containing DMEM with 1% BSA. After incubation for 24 h, invaded cells on the lower side of the insert were stained with Giemsa solution. The invading cells were observed under a confocal microscope and counted from three random fields of Â 10 magnification. Assays were performed in triplicates. The results are presented as the mean±s.e. of triplicate samples.
Scanning electron microscopy
Cells were washed with PBS, fixed with glutaraldehyde solution and washed with PBS. Alcohol dehydration was followed using graded ethanol changes for 20 min. Samples were critical point dried and gold splattered in vacuum, then subjected to Scanning electron microscopy.
Live cell confocal laser scanning microscopy Cells were plated on glass-bottom microwells and images were acquired using LSM 510 META (Zeiss, Gö ttingen, Germany) confocal laser scanning microscopes using the Â 63 objective. Temperature and CO 2 level were kept constant during images acquisition.
Bleb counting
Image series were acquired at 15 s intervals. Each new bleb received a number and tracked over time. For blebbing frequency, newly formed blebs per minute were counted and statistical data were calculated.
Calculation of bleb parameters
Series of images were acquired at 15 s intervals. Blebs contour were drawn, and area and perimeter measurements were calculated for each frame using Zeiss LSM software.
Quantization of blebbing cells
To calculate the percentage of blebbing cells, several different fields were imaged. The total number of cells and the number of blebbing cells in each field were counted and statistical data were calculated.
Data and image analysis and statistics
Image analysis of average fluorescence intensity per pixel was performed using MICA image analysis software (Cytoview, Israel) or ImageJ (NIH, Bethesda, MD, USA). Statistical analysis was performed with the statistical tool kit in Microsoft Excel or with SPSS. A Student's t-test was used for comparison between two groups. Po0.05 was considered statistically significant.
